MPLT Earnings Date: Dec 3, 2026 (Estimated) — MapLight Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is MPLT's next earnings date?
MapLight Therapeutics, Inc. (MPLT) is expected to report Q3 2026 earnings on Thursday, December 3, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$1.22.
How did MPLT do in its last earnings report?
In its most recent report on Sep 18, 2026, MapLight Therapeutics, Inc. posted EPS of -$1.32 versus the -$1.35 estimate, a beat of 2.1%. The stock's 1-day post-earnings move was -3.7%.
How much does MPLT stock move after earnings?
MPLT beat EPS estimates in 2 of its last 5 reported quarters. Over the last 5 reports the stock moved an average of 4.3% (up or down) in the day after earnings.
About MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for individuals grappling with severe central nervous system (CNS) disorders. Its pipeline features several promising therapeutic candidates: ML-007C-MA, a fixed-dose combination of an M1/M4 muscarinic agonist, is being advanced to address symptoms of schizophrenia and Alzheimer's disease psychosis. Additionally, the company is investigating ML-004 for its potential to alleviate social communication deficits and irritability associated with autism spectrum disorder, while ML-021 is designed to target motor impairments seen in Parkinson's disease. Furthermore, ML-009, a G-protein-coupled receptor 52 positive allosteric modulator, is under development for conditions involving hyperactivity, impulsivity, and agitation. Beyond its drug portfolio, MapLight has also established a proprietary platform focused on identifying neural circuits fundamentally linked to disease and then precisely modulating these circuits for therapeutic benefit. Established in 2018 under its former name, Alvarado Therapeutics, Inc., the company adopted the MapLight Therapeutics, Inc. identity in August 2019. Based in Redwood City, California, it operates as a subsidiary of Catalyst4, Inc.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-18 | -1.35 | -1.32 | +2.15% | — | ✅ Beat | -3.71% | -4.95% | -31.98% | |
| 2026-08-13 | Q2 2026 | -1.35 | -1.32 | +0.75% | $0 | ✅ Beat | +1.47% | -3.02% | +13.56% |
| 2026-05-14 | Q1 2026 | -1.08 | -1.34 | -24.07% | $0 | ❌ Miss | -1.91% | -0.03% | -4.54% |
| 2026-03-26 | Q4 2025 | -0.92 | -2.47 | -168.48% | $0 | ❌ Miss | +6.01% | +14.83% | +64.06% |
| 2025-12-04 | Q3 2025 | -1.36 | -37.18 | -2633.82% | $0 | ❌ Miss | +8.39% | +20.63% | +1.77% |
Showing last 5 quarters.